ATC Group: G01AF08 Tioconazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G01AF08 in the ATC hierarchy

Level Code Title
1 G Genito urinary system and sex hormones
2 G01 Gynecological antiinfectives and antiseptics
3 G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
4 G01AF Imidazole derivatives
5 G01AF08 Tioconazole

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Route Amount
VAGIN - Vaginal 0.3 g

Active ingredients in G01AF08

Active Ingredient Description
Tioconazole

Tioconazole is an imidazole derivative. Tioconazole is a broad spectrum antifungal agent that also has an antibacterial effect on a number of Gram-positive cocci (e.g. Stapphylococcus, Streptococcus species). It is active against commonly occurring dermatophyte and yeast-like fungal species.

Medicines in this ATC group

France (FR)

Hong Kong (HK)

Turkey (TR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.